MEK inhibitors against MET-amplified non-small cell lung cancer

Several receptor tyrosine kinases (RTKs) including EGFR, ALK, and MET have been identified as therapeutic targets in non-small cell lung cancer (NSCLC). Among the downstream pathways of RTKs, the MAPK pathway is particularly important for cancer cell proliferation, differentiation, and survival. In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Oncol
Main Authors: Chiba, Masato, Togashi, Yosuke, Tomida, Shuta, Mizuuchi, Hiroshi, Nakamura, Yu, Banno, Eri, Hayashi, Hidetoshi, Terashima, Masato, De Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Mitsudomi, Tetsuya, Nishio, Kazuto
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118002/
https://ncbi.nlm.nih.gov/pubmed/27748834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados